WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Ownership - Who owns Sarepta Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sarepta Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ryan Hoyan WongChief Financial Officer2025-07-31327$16.42
$5.37kSell
Richard BarryDirector2025-05-1612,350$32.63
$402.98kBuy
Richard BarryDirector2025-05-139,746$25.18
$245.40kBuy
Richard BarryDirector2025-05-1310,500$13.71
$143.96kBuy
Claude NicaiseDirector2025-03-122,491$99.64
$248.20kSell
Claude NicaiseDirector2025-03-129,746$25.18
$245.40kBuy
Louise RodinoklapacHead of RD CSO2025-03-10924$100.13
$92.52kSell
Dallan MurrayChief Customer Officer2025-03-10996$100.13
$99.73kSell
Dallan MurrayChief Customer Officer2025-03-102,737$100.13
$274.06kSell
Ian Michael EstepanChief Financial Officer2025-03-102,890$100.13
$289.38kSell

1 of 5

SRPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SRPT insiders and whales buy or sell their stock.

SRPT Shareholders

What type of owners hold Sarepta Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.40%12,115,222$244.97MInstitution
Black Bear Offshore Master Fund LP10.15%9,914,211$200.47MInsider
Vanguard Group Inc9.37%9,160,179$185.22MInstitution
Eastbourne Capital Management LLC5.79%5,659,211$114.43MInsider
State Street Corp4.80%4,695,027$94.93MInstitution
D E Shaw Co Inc4.58%4,478,638$90.56MInstitution
Richard Barry3.29%3,216,667$65.04MInsider
Rockall Emerging Markets Master Fund Ltd3.00%2,935,696$59.36MInsider
Wellington Management Group LLP2.59%2,530,455$51.17MInstitution
George Weaver Haywood2.48%2,426,953$49.07MInsider

1 of 3

SRPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SRPT74.07%25.93%Net SellingNet Selling
ADPT62.47%37.53%Net Selling
ARQT76.76%23.24%Net SellingNet Selling
BLTE0.25%0.00%
CGON88.77%11.23%Net SellingNet Buying
View Top Biotech Stocks

Sarepta Therapeutics Stock Ownership FAQ

Who owns Sarepta Therapeutics?

Sarepta Therapeutics (NASDAQ: SRPT) is owned by 84.66% institutional shareholders, 29.64% Sarepta Therapeutics insiders, and 0.00% retail investors. Black Bear Offshore Master Fund LP is the largest individual Sarepta Therapeutics shareholder, owning 9.91M shares representing 10.15% of the company. Black Bear Offshore Master Fund LP's Sarepta Therapeutics shares are currently valued at $200.47M.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.